StockData
Kiniksa Pharmaceuticals International, plc logo

Kiniksa Pharmaceuticals International, plc (KNSA) stock

KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30469% above fair value
$95.05−0.06 (-0.06%)

Close on Nov 18, 2026Market cap $14.94BP/E 73.1Yield –

Kiniksa Pharmaceuticals International market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kiniksa Pharmaceuticals International's market cap was $7.84B on Nov 11, 2026, against $3.26B a year earlier. Over the last 5 years it ranged from $526.95M to $7.84B, with a median of $1.43B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.84B+148.2%
2025Dec 31, 2025$3.16B+119.5%
2024Dec 31, 2024$1.44B+16.3%
2023Dec 29, 2023$1.24B+19.0%
2022Dec 30, 2022$1.04B+29.4%
2021Dec 31, 2021$804.58M-22.2%
2020Dec 31, 2020$1.03B+78.3%
2019Dec 31, 2019$579.90M+16.0%
2018Dec 31, 2018$500.03M–

More Kiniksa Pharmaceuticals International figures

See a number that looks wrong?